Skip to main content

Table 3 Association between CML and clinical characteristics of the whole cohort, normotensive and hypertensive subjects

From: Association between carotid diameter and the advanced glycation endproduct Nε-Carboxymethyllysine (CML)

 

Total cohort

Normotension

Hypertension

r

P value

r

P value

r

P value

Age

-0.17

0.10

-0.13

0.29

-0.17

0.34

Sex

-0.04

0.76

-0.15

0.24

0.19

0.30

BMI

0.05

0.60

0.01

0.99

0.17

0.33

Smoking

0.03

0.75

-0.02

0.88

0.05

0.78

SBP

0.02

0.81

0.09

0.46

0.30

0.09

DBP

-0.05

0.58

-0.04

0.73

0.17

0.34

PP

0.12

0.22

0.14

0.26

0.16

0.37

Creatinine

-0.10

0.37

-0.03

0.82

-0.11

0.54

Glucose

0.05

0.61

-0.08

0.55

0.13

0.46

Cholesterol

0.20

0.05

0.23

0.06

0.15

0.40

HDL

0.17

0.08

0.08

0.53

0.31

0.07

LDL

0.21

0.04

0.27

0.03

0.15

0.41

Triglycerides

-0.07

0.52

-0.04

0.71

-0.09

0.63

Fetuin

0.28

0.01

0.27

0.03

0.34

0.04

PWV

-0.12

0.23

-0.20

0.10

0.06

0.75

Common carotid artery

IMT

0.08

0.45

0.15

0.25

-0.06

0.72

Diameter

0.18

0.07

-0.01

0.93

0.42

0.01

Pulse pressure

0.10

0.34

0.09

0.48

0.18

0.31

CC

0.12

0.26

-0.07

0.56

0.26

0.14

DC

0.11

0.30

0.01

0.99

0.21

0.23

  1. Spearman correlation coefficient Bold: P < 0.05
  2. CML: NεCarboxymethyllysine, BMI: body mass index, SBP: systolic blood pressure, DBP: diastolic blood pressure, PP: pulse pressure, PWV: pulse wave velocity, IMT: intima media thickness, CC: cross-sectional compliance, DC: distensibility coefficient
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840